Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

• Published in: The oncologist (Dayton, Ohio) Vol. 24; no. 11; pp. e1236 - e1250
• Main Authors: Matasar, Matthew J., Luminari, Stefano, Barr, Paul M., Barta, Stefan K., Danilov, Alexey V., Hill, Brian T., Phillips, Tycel J., Jerkeman, Mats, Magagnoli, Massimo, Nastoupil, Loretta J., Persky, Daniel O., Okosun, Jessica
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.11.2019
• Subjects: Antineoplastic agents; Follicular lymphoma; Hematologic Malignancies; Neoplasms; Non‐Hodgkin lymphoma; Follicular lymphoma; Antineoplastic agents; Neoplasms; Non‐Hodgkin lymphoma

Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to differences in clinical, laboratory, and disease parameters. Although generally considered incurable, prognosis for early‐ and advanced‐stage disease has improved because of therapeutic advances, several of which hav...